News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
150,673 Results
Type
Article (14417)
Company Profile (14)
Press Release (136242)
Multimedia
Podcasts (2)
Webinars (3)
Section
Business (39510)
Career Advice (207)
Deals (5343)
Drug Delivery (18)
Drug Development (18557)
Employer Resources (25)
FDA (2884)
Job Trends (3190)
News (65651)
Policy (5358)
Tag
Academia (1706)
Accelerated approval (3)
Adcomms (11)
Allergies (21)
Alliances (12591)
ALS (50)
Alzheimer's disease (560)
Antibody-drug conjugate (ADC) (46)
Approvals (2974)
Artificial intelligence (129)
Autoimmune disease (19)
Automation (7)
Bankruptcy (32)
Best Places to Work (2719)
BIOSECURE Act (14)
Biosimilars (17)
Biotechnology (9)
Bladder cancer (46)
Brain cancer (23)
Breast cancer (199)
Cancer (1420)
Cardiovascular disease (70)
Career advice (197)
Career pathing (4)
CAR-T (83)
CDC (6)
Cell therapy (185)
Cervical cancer (14)
Clinical research (15037)
Collaboration (387)
Compensation (27)
Complete response letters (6)
COVID-19 (1058)
CRISPR (27)
C-suite (176)
Cystic fibrosis (30)
Data (1402)
Denatured (1)
Depression (22)
Diabetes (71)
Diagnostics (1709)
Digital health (8)
Diversity (3)
Diversity, equity & inclusion (9)
Drug discovery (62)
Drug pricing (28)
Drug shortages (1)
Duchenne muscular dystrophy (25)
Earnings (9517)
Editorial (12)
Employer branding (3)
Employer resources (21)
Events (19572)
Executive appointments (188)
FDA (3496)
Friedreich's ataxia (4)
Frontotemporal dementia (13)
Funding (529)
Gene editing (45)
Generative AI (4)
Gene therapy (149)
GLP-1 (119)
Government (1196)
Grass and pollen (1)
Guidances (68)
Healthcare (4843)
HIV (12)
Huntington's disease (4)
IgA nephropathy (6)
Immunology and inflammation (28)
Immuno-oncology (12)
Indications (21)
Infectious disease (1109)
Inflammatory bowel disease (47)
Inflation Reduction Act (2)
Influenza (18)
Intellectual property (34)
Interviews (19)
IPO (2750)
IRA (13)
Job creations (549)
Job search strategy (186)
JPM (3)
Kidney cancer (9)
Labor market (23)
Layoffs (57)
Leadership (2)
Legal (927)
Liver cancer (25)
Longevity (4)
Lung cancer (185)
Lymphoma (124)
Machine learning (10)
Management (6)
Manufacturing (124)
MASH (29)
Medical device (2493)
Medtech (2495)
Mergers & acquisitions (2848)
Metabolic disorders (136)
Multiple sclerosis (40)
NASH (4)
Neurodegenerative disease (68)
Neuropsychiatric disorders (12)
Neuroscience (862)
NextGen: Class of 2026 (1610)
Non-profit (1883)
Now hiring (6)
Obesity (36)
Opinion (57)
Ovarian cancer (47)
Pain (38)
Pancreatic cancer (58)
Parkinson's disease (72)
Partnered (10)
Patents (65)
Patient recruitment (105)
Peanut (11)
People (15525)
Pharmaceutical (5)
Pharmacy benefit managers (2)
Phase 1 (5091)
Phase 2 (6879)
Phase 3 (4565)
Pipeline (990)
Policy (74)
Postmarket research (547)
Preclinical (2291)
Press Release (18)
Prostate cancer (73)
Psychedelics (11)
Radiopharmaceuticals (54)
Rare diseases (150)
Real estate (1213)
Recruiting (12)
Regulatory (4046)
Reports (10)
Research institute (1929)
Resumes & cover letters (16)
Rett syndrome (2)
RNA editing (2)
RSV (8)
Schizophrenia (35)
Series A (69)
Series B (41)
Sickle cell disease (28)
Special edition (1)
Spinal muscular atrophy (25)
Sponsored (2)
Startups (1075)
Stomach cancer (3)
Supply chain (20)
Tariffs (10)
The Weekly (1)
Vaccines (280)
Venture capital (23)
Weight loss (16)
Women's health (15)
Worklife (3)
Date
Today (2)
Last 7 days (100)
Last 30 days (401)
Last 365 days (5777)
2026 (484)
2025 (5915)
2024 (7219)
2023 (8724)
2022 (11563)
2021 (12896)
2020 (12195)
2019 (10947)
2018 (8106)
2017 (7359)
2016 (7419)
2015 (8727)
2014 (6474)
2013 (5336)
2012 (5415)
2011 (5641)
2010 (4820)
Location
Africa (195)
Alabama (55)
Alaska (3)
Arizona (70)
Arkansas (3)
Asia (9461)
Australia (2104)
California (1926)
Canada (537)
China (161)
Colorado (99)
Connecticut (87)
Delaware (100)
Europe (19868)
Florida (380)
Georgia (54)
Idaho (12)
Illinois (186)
India (13)
Indiana (74)
Iowa (7)
Japan (102)
Kansas (23)
Kentucky (16)
Louisiana (5)
Maine (10)
Maryland (287)
Massachusetts (1404)
Michigan (40)
Minnesota (114)
Mississippi (1)
Missouri (38)
Montana (7)
Nebraska (4)
Nevada (10)
New Hampshire (14)
New Jersey (795)
New Mexico (6)
New York (692)
North Carolina (233)
North Dakota (3)
Northern California (916)
Ohio (68)
Oklahoma (7)
Oregon (8)
Pennsylvania (407)
Puerto Rico (3)
Rhode Island (11)
South America (260)
South Carolina (11)
Southern California (734)
Tennessee (47)
Texas (452)
United States (7872)
Utah (58)
Vermont (1)
Virginia (54)
Washington D.C. (36)
Washington State (204)
West Virginia (2)
Wisconsin (23)
150,673 Results for "institut gustave roussy".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
StarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive Cancers
January 27, 2026
·
4 min read
Press Releases
MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in Advanced NSCLC Patients with Antibiotic-Induced Dysbiosis
January 21, 2026
·
6 min read
Press Releases
Aitia and Gustave Roussy Join Forces to Identify the Fundamental Biological Causes of Multiple Human Cancers
June 5, 2025
·
4 min read
Press Releases
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
March 18, 2025
·
4 min read
Business
Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France
Sofinnova Partners and Gustave Roussy announced the launch of a strategic collaboration as part of Sofinnova Biovelocita, the first pan-European investment strategy dedicated to the creation and acceleration of biotech startups.
December 13, 2023
·
5 min read
Business
SOPHiA GENETICS Expands Relationship with Gustave Roussy
SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced the expansion of its relationship with Gustave Roussy, the leading cancer center in Europe.
August 22, 2023
·
5 min read
Business
Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies
Partnership will leverage Gustave Roussy’s tumor samples and Veracyte’s Biopharma Atlas multi-omic database and machine learning capabilities.
September 6, 2023
·
6 min read
BioMidwest
Spectrum Dynamics is proud to announce the Installation of the VERITON-CT SPECT/CT imaging system at European Leading Cancer Center, Gustave Roussy
Spectrum Dynamics Medical, a leading innovator in diagnostic imaging solutions, announced that its VERITON-CT 400, a new generation of digital SPECT/CT was successfully installed and patient scanning was started at Gustave Roussy, Grand Paris, France.
March 20, 2024
·
3 min read
Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients
Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy.
July 12, 2023
·
3 min read
Pharm Country
The Gustave Roussy Institute Integrates Synapse Platform to Ensure Complex Prescription Safety
France’s Gustave Roussy Institute, Europe’s leading cancer center and ranked third in the world according to Newsweek Magazine, has chosen to partner with Synapse Medicine, a leader in clinical pharmacy and medication reconciliation.
December 1, 2022
·
4 min read
1 of 15,068
Next
